Chen, J., Xie, C., Yang, Y., Yang, S., Huang, J., Ye, F., . . . Liu, J. (2023). Association between albumin-to-globulin ratio and the risk of overall survival in advanced non-small cell lung cancer patients with anlotinib treatment: A retrospective cohort study. BMC pulmonary medicine, 23(1), 275-10. https://doi.org/10.1186/s12890-023-02574-6
Chicago Style (17th ed.) CitationChen, Jinzhan, Congyi Xie, Yimin Yang, Shuwen Yang, Jinxian Huang, Feiyang Ye, Zhenyang Lin, Lin Tong, and Jiaxin Liu. "Association Between Albumin-to-globulin Ratio and the Risk of Overall Survival in Advanced Non-small Cell Lung Cancer Patients with Anlotinib Treatment: A Retrospective Cohort Study." BMC Pulmonary Medicine 23, no. 1 (2023): 275-10. https://doi.org/10.1186/s12890-023-02574-6.
MLA (9th ed.) CitationChen, Jinzhan, et al. "Association Between Albumin-to-globulin Ratio and the Risk of Overall Survival in Advanced Non-small Cell Lung Cancer Patients with Anlotinib Treatment: A Retrospective Cohort Study." BMC Pulmonary Medicine, vol. 23, no. 1, 2023, pp. 275-10, https://doi.org/10.1186/s12890-023-02574-6.